Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-722-4 | CAS number: 26471-62-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity: oral
In an NTP
study similar to OECD Guideline 401 with rats and mice (NTP, 1986), an
LD50 > 2000 mg/kg bw was determined.
Acute toxicity: dermal
In a dermal acute toxicity study according to OECD Guideline 402 in rabbits (Wazeter, 1964), an LD50 > 2000 mg/kg was determined.
Acute toxicity: inhalation
In an inhalation study according to OECD Guideline 403 in rats
(Doe/Horspool, 1980), an LC50 = 0.48 mg/L was determined.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- data not available
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Remarks:
- / TDI isomer ratio is specified but the purity is not stated.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Frederick Cancer Research Center (Frederick MD)
- Age at study initiation: ~10 weeks
- Weight at study initiation: ♀: 144 - 163 g ; ♂: 222 - 272 g
- Housing: two or three per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: ~6 weeks - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 500 mg/mL
- Preparation: within 2 h of dosing
- Doses:
- 2150, 3160, 4640, 6810, 10000, 14700 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations (1) and weighing (2):
(1) Observations for mortality: every 30 minutes for the first 8 hours, then daily for the rest of the study.
(2) Weighing: on test day 1 (prior to administration) and on day 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs. - Statistics:
- no statistical analysis was used
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 5 110 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 4 130 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Yes. Mortality increased proportionally to the dose of substance administered. For more details see table 1 in the text field "remarks on results including tables and figures".
- Clinical signs:
- other: At 10000 or 14700 mg/kg death was preceded by laboured breathing, inactivity and diarrhea.
- Gross pathology:
- No macroscopic findings were reported.
- Other findings:
- White crystals in stomach and dark red lungs were found at necropsy. The findings were regarded as dose related.
- Interpretation of results:
- GHS criteria not met
Reference
Table 1: Number of animals dead and time range within which mortality occured
Dose (mg/kg bw) |
Mortality (# dead/total) | Time range of deaths (days) | ||
Male | Female | Combined | ||
2150 | 2/5 | 0/5 | 2/10 | (5-9) |
3160 | 3/5 | 2/5 | 5/10 | (1-14) |
4640 | 2/5 | 2/5 | 4/10 | (2-10) |
6810 | 2/5 | 5/5 | 7/10 | (2-5) |
10000 | 5/5 | 4/5 | 9/10 | (1-3) |
14700 | 5/5 | 5/5 | 10/10 | (1-2) |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Klimisch code 2
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1977-06-16 to 1977-07-30
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- The duration of exposure was 1 h instead of at least 4 h. 4 animals per sex instead of 5. The humidity was low (4 %) instead of 30 - 70 %.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: ABH2146
OTHER SPECIFICS:
- Isomers composition: 79.6 % (2,4 isomer) - Species:
- rat
- Strain:
- other: Alderly Park
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 6 - 10 weeks
- Weight at study initiation: 150 - 300 g
- Fasting period before study: none
- Housing: 4 rats/cage
- Diet : ad libitum except during the exposure, Oakes Powder 'O' diet
- Water : ad libitum, except during the exposure - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: heated tube
- Exposure chamber volume: a 17 L glass dessicator was used as an exposure chamber (there were no divisions in order to minimise deposition).
- Method of conditioning air: The TDI was dispended into a syringe atomizer by a palmer slow injection apparatus (CF palmer limited). The entrained vapour passed through a heated glass tube (about 120 °C), mixed with diluting air and led into the animal exposure chamber. All air was dried to less than 4 % relative humidity.
- Temperature, humidity, pressure in air chamber: no data, 4 %, no data
TEST ATMOSPHERE
- Brief description of analytical method used: The test atmosphere is drawn throught a glass sintered bubbler containing absolute alcohol. The Isocyanate (Urethane derivative) is subsequently analysed by Liquid Chromatography.
- Samples taken from breathing zone: yes
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- A sample of air from the breathing zone of the rats was drawn through two sintered glass absorbers containing 10 mL of absolute alcohol at a rate of 1.25 L/min for 5 min mid-way through each exposure. The trapped isocyanates were then analysed by HPLC.
- Duration of exposure:
- 1 h
- Concentrations:
- 0, 17.4, 25.16, 43.2, 83.9, and 267.1 ppm (0.13, 0.18, 0.31, 0.61, and 1.93 mg/L)
- No. of animals per sex per dose:
- 4
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: at least 14 days
- Frequency of observations and weighing: The behaviour of the animals was recorded throughout the exposure. Then, examination and weighing during the following fourteen days were performed at approximately 2 days intervals.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, lung weight - Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 66 ppm
- Based on:
- test mat.
- 95% CL:
- > 31 - < 141
- Exp. duration:
- 1 h
- Remarks on result:
- other: (LC50 = 0.48 mg/L) There was no significant difference between the LC50 of male and female rats.
- Mortality:
- Yes, 11/18 deaths occurred on day 1 or 2. For more details see table 1 in field "Remarks on results including tables and figures".
- Clinical signs:
- other: At 17.4 ppm: after exposure, all animals were subdued and wheezing. Animals were hunched and blue. 2 females lost weight over 10 days. 1 female died on day 15 and 1 was sacrificed in extremis. At 25.16 ppm: after exposure, all animals were wheezing
- Body weight:
- All of the animals exposed which survived the first 36 hours after exposure lost weight during the first 4 days of the observation period. Some continued to lose weight and either died or were sacrificed.
- Gross pathology:
- See remarks.
- Other findings:
- - Potential target organs: lung
- Organ weights: The lung weights were increased indicating oedema.
- Other observations: Necropsy findings:
(1) At 17.4 ppm, 1 female died on day 15 had dark patches on all lobes of lungs; the animal sacrificed on day 15 had pale inflated lungs with red 2 lobes of right lung; lung weight was high.
(2) At 25.16 ppm: 1 female dying on day 2 had multiple dark red foci on all lung lobes, 2 dark red lobes; others sacrificed at end of study had red foci on lungs and consolidated lobes; 3 males had pale inflated lungs; lung weights were increased.
(3) At 43.2 ppm: animals dying had inflated lungs with dark patches full of fluid; at necropsy, lung weights increased and all lungs were pale, inflated with 2 animals showing dark patches.
(4) At 83.9 ppm: animals dying on study had red foci in lungs and animals surviving had inflated and pale lungs except for red areas of consolidation, lung weights were increased.
(5) At 267.1 ppm: animals dying on day 1 had fluid in lung and thorax, animals dying after day 1 had inflated, red lungs; single survivor had pale enlarged lungs with red spots on all lobes, enlarged adrenals and gray kidneys. - Interpretation of results:
- Category 2 based on GHS criteria
Reference
Table 1: Concentrations, time of death and mortality per animals treated
Conc. (ppm) |
Isomer ratio 2,4:2,6 |
Mortality (# dead/total) | Time range of deaths (days) | ||
Male | Female | Combined | |||
17.4 | 3.13:1 | 0/4 | 1/4 | 1/8 | day 15 |
25.16 | 2.53:1 | 1/4 | 3/4 | 4/8 | (2-19) |
43.2 | 4.1:1 | 2/4 | 1/4 | 3/8 | (2-11) |
83.9 | 3.13:1 | 1/4 | 2/4 | 3/8 | (2-4) |
267.1 | 2.27:1 | 4/4 | 3/4 | 7/8 | (1-2) |
controls | - | 0/4 | 0/4 | 0/8 | - |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 0.48 µg/m³ air
- Quality of whole database:
- Klimisch code 2
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- Two rabbits/sex instead of 5 were tested per group. The skin of half the rabbits in each group was abraded by producing shallow incisions with a scalpel blade.TDI isomer ratio and purity not specified.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 2215 - 3180 g
- Housing: individually in metal cages
- Diet: ad libitum
- Water: ad libitum- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: ~ 3 inches²
- Type of wrap if used: non-occlusive dressing
REMOVAL OF TEST SUBSTANCE
- Washing: yes
- Time after start of exposure: 24 h
TEST MATERIAL
- Amounts applied: doses of 2500 - 9400 mg/kg
OTHER
TDI applied undiluted to intact or abraded skin of 2 male and 2 female rabbits at doses of 2500 - 9400 mg/kg. The dorsal skin of each rabbit was prepared for treatment by close clipping of the hair with an electric clipper. In addition, the skin of half the rabbits in each group was abraded by producing shallow incisions with a scalpel blade over an area approximately three inches square. The compound was applied to each individual animals in the liquid form as received and administered on a volume basis. The animals were observed daily for a total of 14 days for pharmacotoxic signs and dermal irritation. Body weights were obtained for each animal and a complete necropsy was performed on each animal at termination. - Duration of exposure:
- 24 h
- Doses:
- 2500, 3900, 6000, and 9400 mg/kg bw
- No. of animals per sex per dose:
- Four groups of 4 rabbits (2/sex) were used.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations (1) and weighing (2):
(1) Observations occured daily
(2) weighing occured at the beginning and at the end of the study.
- Necropsy of survivors performed: yes
- Other examinations performed: Signs of dermal irritation - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 9 400 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: All animals appeared essentially normal throughout the 14-day observation period.
- Gross pathology:
- All animals at all dosage levels were considered essentially normal at necropsy examination. No potential target organs were observed. No apparent difference between the sexes was observed.
- Other findings:
- - Other observations: Dermal irritation was seen at each of the four dosage levels. Peak irritation occurred between the 5th and 10th day after application. During this time, erythema, edema, atonia, and coriaceousness were observed in most cases to a moderate-to-marked degree. From the 8th to the 14th day, moderate-to-marked desquamation and fissuring were observed. This condition subsided by the termination of the study.
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Klimisch code 2
Additional information
Acute toxicity: oral
Several tests assessing the oral toxicity of TDI in rats or mice of both sexes are available. A limit test performed by the Ministry of Health of Japan (2001) showed in rats an LD50 value of > 2000 mg/kg bw for both sexes. An NTP study with rats and mice showed also LD50 values > 2000 mg/kg bw (Rat: LD50male= 5110 mg/kg bw; LD50female= 4130 mg/kg bw/ Mice: LD50male = 4130 mg/kg bw; LD50female= 5620 mg/kg bw). At necropsy, white crystalline material was found in the stomach and dark red lungs were observed. In Wazeter F.X. (1964), the acute oral LD50male value was determined to be 5840 mg/kg bw. White granular particles were also found in the stomach, and hypoactivity and reduced pain response were observed. Overall, tests assessing the acute oral toxicity of TDI provide consistent evidence of low toxicity after an oral administration.
Acute toxicity: dermal
One study is available for this endpoint. TDI (unspecified isomers) was dermally administered to rabbits. No mortality occured and animals appeared normal throughout the 14-day observation period but skin irritation was noted at all dose levels (2500 to 9400 mg/kg b.w.), at a moderate-to-marked degree. This result shows that TDI is not acutely toxic via the dermal route. The LD50 was > 9400 mg/kg b.w. in rabbits (Wazeter et al., 1964).
Acute toxicity: inhalation
Two reliable studies for the assessment of the inhalation toxicity of TDI are available. Doe and Horspool (1980) determined the 1-hour LC50 in rats at 66 ppm (0.47 mg/L). All animals were exposed whole-body. Animals dying on study or sacrificed at the end of exposure revealed some hemorrhages or edema of the lungs. As part of a micronucleus study, a 6-hour inhalation exposure with a four-day observation period was performed using mice (Mackay, 1992). Exposures were whole body to 80:20 TDI. The LC50 was 14 ppm (0.1 mg/L) for females and 19 ppm (0.14 mg/L) for males. Overall, these results show that TDI is very toxic by inhalation for males. Overall, these results show that TDI is very toxic by inhalation.
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008.
Discriminating doses for acute oral (> 2000 mg/kg bw) and acute dermal (> 2000 mg/kg bw) toxicity were determined. As a result the substance is not considered to be classified for acute oral or dermal toxicity under Regulation (EC) No 1272/2008, as amended for the tenth time in Regulation (EU) No 2017/776.
TDI has a harmonized classification for acute inhalative toxicity, Category 2 (H330) under Regulation (EC) No 1272/2008. However, the 1-hour LC50 of 0.48 mg/L determined in the key study for this endpoint (Doe and Horspool, 1980) warrants a more severe classification into Category 1 (H330), which is hence adopted as self-classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.